A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA

被引：0
|
作者：
Grainger, J. [1 ]
Bussel, J. [2 ]
Cooper, N. [3 ]
Tarantino, M. [4 ]
Blanchette, V. [5 ]
Despotovic, J. [6 ]
Maschan, A. [7 ]
Carpenter, N. [8 ]
Eisen, M. [9 ]
Mehta, B. [9 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Weill Cornell Med, New York, NY USA
[3] Imperial Coll, Hammersmith Hosp, London, England
[4] Bleeding & Clotting Disorders Inst, Peoria, IL USA
[5] Hosp Sick Children, Toronto, ON, Canada
[6] Texas Childrens Hematol Ctr, Houston, TX USA
[7] Fed Res Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia
[8] Amgen Ltd, Uxbridge, Middx, England
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P367
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [11] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Bussel, J.
    Tarantino, M.
    Blanchette, V.
    Raj, A.
    Despotovic, J.
    Beam, D.
    Roy, J.
    Wang, X.
    Mehta, B.
    Eisen, M.
    HAEMATOLOGICA, 2017, 102 : 294 - 294
  • [12] Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
    Tarantino, Michael
    Bussel, James B.
    Blanchette, Victor S.
    Beam, Donald
    Roy, John
    Despotovic, Jenny M.
    Raj, Ashok
    Carpenter, Nancy
    Mehta, Bhakti
    Eisen, Melissa
    BLOOD, 2017, 130
  • [13] FINAL SAFETY AND EFFICACY DATA OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Tarantino, Michael
    Bussel, James
    Blanchette, Victor
    Beam, Donald
    Roy, John
    Despotovic, Jenny
    Raj, Ashok
    Carpenter, Nancy
    Mehta, Bhaki
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [14] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)
    Tarantino, Michael D.
    Bussel, James B.
    Blanchette, Victor S.
    Despotovic, Jenny M.
    Bennett, Carolyn
    Raj, Ashok
    Williams, Bronwyn
    Beam, Donald
    Morales, Jaime
    Rose, Melissa J.
    Nie, Kun
    Eisen, Melissa
    BLOOD, 2015, 126 (23)
  • [15] Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
    Tarantino, Michael D.
    Bussel, James B.
    Geddis, Amy
    Guerrera, Michael F.
    Ikeda, Alan K.
    Nie, Kun
    Eisen, Melissa
    BLOOD, 2013, 122 (21)
  • [16] Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)
    Bussel, James B.
    Tarantino, Michael D.
    Geddis, Amy
    Guerrera, Michael F.
    Ikeda, Alan K.
    Nie, Kun
    Franklin, Janet
    Eisen, Melissa
    BLOOD, 2014, 124 (21)
  • [17] Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study
    Kuter, David J.
    Bussel, James B.
    Newland, Adrian
    Wasser, Jeffrey S.
    Lyons, Roger M.
    George, James N.
    Macik, Gail
    Nie, Kun
    Jun, Susie
    BLOOD, 2010, 116 (21) : 36 - 37
  • [18] Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
    Saleh, Mansoor N.
    Bussel, James B.
    Cheng, Gregory
    Meyer, Oliver
    Bailey, Christine K.
    Arning, Michael
    Brainsky, Andres
    BLOOD, 2013, 121 (03) : 537 - 545
  • [19] A Prospective Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Lusutrombopag in Chinese Adults with Persistent or Chronic Primary Immune Thrombocytopenia
    Fu, Rongfeng
    Liu, Xiaofan
    Qu, Xinmiao
    Xue, Feng
    Liu, Wei
    Chen, Yunfei
    Sun, Ting
    Ju, Mankai
    Dong, Huan
    Gu, Wenjing
    Dai, Xinyue
    Yang, Renchi
    Zhang, Lei
    BLOOD, 2024, 144 : 5438 - 5439
  • [20] Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study
    Mei, Heng
    Chen, Xiequn
    Zhou, Jianfeng
    Luo, Jianmin
    Shi, Qingzhi
    Liu, Jing
    Wu, Depei
    Chen, Guoan
    Tai, Yanfei
    Xiong, Junye
    Zou, Jianjun
    Hu, Yu
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
12345